|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16396056
|
Filing Dt:
|
04/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2019
| | | | |
|
Title:
|
PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/16/2021
|
Application #:
|
16397172
|
Filing Dt:
|
04/29/2019
|
|
Publication #:
|
|
Pub Dt:
|
08/15/2019
| | | | |
|
Title:
|
OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/09/2021
|
Application #:
|
16415455
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
|
Title:
|
PD1 AND/OR LAG3 BINDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/09/2021
|
Application #:
|
16415496
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
|
Title:
|
PD1 AND/OR LAG3 BINDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/26/2021
|
Application #:
|
16415530
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
|
Title:
|
PD1 AND/OR LAG3 BINDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/18/2021
|
Application #:
|
16434729
|
Filing Dt:
|
06/07/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/02/2020
| | | | |
|
Title:
|
ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/10/2020
|
Application #:
|
16447271
|
Filing Dt:
|
06/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/27/2021
|
Application #:
|
16461569
|
Filing Dt:
|
05/16/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | | | |
|
Title:
|
ANTIDIABETIC HETEROCYCLIC COMPOUNDS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/25/2021
|
Application #:
|
16461825
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
08/20/2020
| | | | |
|
Title:
|
Factor XIIa Inhibitors
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/29/2020
|
Application #:
|
16461849
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/21/2019
| | | | |
|
Title:
|
Factor XIIa Inhibitors
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/16/2021
|
Application #:
|
16461880
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2019
| | | | |
|
Title:
|
INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/31/2021
|
Application #:
|
16461902
|
Filing Dt:
|
05/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
|
Title:
|
INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/15/2020
|
Application #:
|
16462344
|
Filing Dt:
|
05/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/05/2019
| | | | |
|
Title:
|
HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/16/2021
|
Application #:
|
16462354
|
Filing Dt:
|
05/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/05/2019
| | | | |
|
Title:
|
Manually-Actuated Injection Device for High-Viscosity Drugs
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/06/2021
|
Application #:
|
16465156
|
Filing Dt:
|
05/30/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
|
Title:
|
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/02/2021
|
Application #:
|
16465614
|
Filing Dt:
|
05/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/16/2020
| | | | |
|
Title:
|
TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/30/2020
|
Application #:
|
16466783
|
Filing Dt:
|
06/05/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
|
Title:
|
HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/08/2020
|
Application #:
|
16468465
|
Filing Dt:
|
06/11/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
|
Title:
|
AMINOPYRAZOLES AS JANUS KINASE INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/21/2021
|
Application #:
|
16471304
|
Filing Dt:
|
06/19/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/24/2019
| | | | |
|
Title:
|
ANTIVIRAL BENZYL-AMINE PHOSPHODIAMIDE COMPOUNDS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/25/2022
|
Application #:
|
16471672
|
Filing Dt:
|
06/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
|
Title:
|
6,5-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2020
|
Application #:
|
16471675
|
Filing Dt:
|
06/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
6,6-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2022
|
Application #:
|
16471679
|
Filing Dt:
|
06/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/29/2020
|
Application #:
|
16479997
|
Filing Dt:
|
07/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | | | |
|
Title:
|
SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/14/2021
|
Application #:
|
16482349
|
Filing Dt:
|
07/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/13/2020
| | | | |
|
Title:
|
METHODS FOR MAKING POLYSACCHARIDE-PROTEIN CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/23/2021
|
Application #:
|
16483957
|
Filing Dt:
|
08/06/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
|
Title:
|
NOVEL SUBSTITUTED SULFOXIMINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/17/2021
|
Application #:
|
16487550
|
Filing Dt:
|
08/21/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/20/2020
| | | | |
|
Title:
|
ENHANCING IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/11/2022
|
Application #:
|
16487621
|
Filing Dt:
|
08/21/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
POLYSACCHARIDE-PROTEIN CONJUGATES UTILIZING DIPHTHERIA TOXIN FRAGMENT B AS A CARRIER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16487628
|
Filing Dt:
|
08/21/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
METHODS FOR IMPROVING FILTERABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE REACTIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/25/2020
|
Application #:
|
16490958
|
Filing Dt:
|
09/04/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2020
| | | | |
|
Title:
|
OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/22/2021
|
Application #:
|
16495703
|
Filing Dt:
|
09/19/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/19/2020
| | | | |
|
Title:
|
GLUCOSE RESPONSIVE INSULIN COMPRISING A TRI-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/2021
|
Application #:
|
16495883
|
Filing Dt:
|
09/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/02/2020
| | | | |
|
Title:
|
NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE IDO INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/03/2021
|
Application #:
|
16496182
|
Filing Dt:
|
09/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/17/2020
| | | | |
|
Title:
|
FORMULATION FOR PARENTERAL ADMINISTRATION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/08/2022
|
Application #:
|
16498013
|
Filing Dt:
|
09/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/06/2020
| | | | |
|
Title:
|
ADDITION OF NUCLEASES DIRECTLY TO CELL CULTURE TO FACILITATE DIGESTION AND CLEARANCE OF HOST CELL NUCLEIC ACIDS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16498831
|
Filing Dt:
|
09/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/17/2020
| | | | |
|
Title:
|
ADDITION OF NUCLEASES DIRECTLY TO CELL CULTURE TO FACILITATE DIGESTION AND CLEARANCE OF HOST CELL NUCLEIC ACIDS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16499674
|
Filing Dt:
|
09/30/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/16/2020
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH A COMBINATION OF AN ANTAGONIST OF PD-1 AND AN ANTI-CTLA4 ANTIBODY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/07/2020
|
Application #:
|
16513409
|
Filing Dt:
|
07/16/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
|
Title:
|
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/04/2020
|
Application #:
|
16513417
|
Filing Dt:
|
07/16/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/07/2019
| | | | |
|
Title:
|
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/02/2021
|
Application #:
|
16525458
|
Filing Dt:
|
07/29/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
|
Title:
|
TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/14/2021
|
Application #:
|
16551974
|
Filing Dt:
|
08/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2020
| | | | |
|
Title:
|
PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16574825
|
Filing Dt:
|
09/18/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2020
| | | | |
|
Title:
|
CEFTOLOZANE ANTIBIOTIC COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/28/2021
|
Application #:
|
16597593
|
Filing Dt:
|
10/09/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/07/2020
| | | | |
|
Title:
|
ANTI-LAP ANTIBODY VARIANTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16597894
|
Filing Dt:
|
10/10/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/06/2020
| | | | |
|
Title:
|
METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELTED DISEASES USING SGLT-2 INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/23/2022
|
Application #:
|
16603692
|
Filing Dt:
|
10/08/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/01/2021
| | | | |
|
Title:
|
DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/02/2021
|
Application #:
|
16607412
|
Filing Dt:
|
10/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/05/2020
| | | | |
|
Title:
|
HSV ANTIGENIC PEPTIDES AND HSV PROTEIN VACCINES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/28/2023
|
Application #:
|
16607453
|
Filing Dt:
|
10/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/05/2020
| | | | |
|
Title:
|
PHARMACEUTICAL FORMULATION COMPRISING INCRETIN-INSULIN CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/25/2023
|
Application #:
|
16609612
|
Filing Dt:
|
10/30/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/14/2020
| | | | |
|
Title:
|
STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16609671
|
Filing Dt:
|
10/30/2019
|
|
Publication #:
|
|
Pub Dt:
|
08/20/2020
| | | | |
|
Title:
|
STABLE FORMULATIONS OF ANTI-CTLA4 ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/19/2023
|
Application #:
|
16609961
|
Filing Dt:
|
10/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/20/2020
| | | | |
|
Title:
|
FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND CO-FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16610188
|
Filing Dt:
|
11/01/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/12/2020
| | | | |
|
Title:
|
STABLE FORMULATIONS OF ANTI-TIGIT ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/11/2022
|
Application #:
|
16611624
|
Filing Dt:
|
11/07/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16611813
|
Filing Dt:
|
11/07/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
NEWCASTLE DISEASE VIRUSES AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/16/2021
|
Application #:
|
16620046
|
Filing Dt:
|
12/06/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
|
Title:
|
AZABICYCLO[4.1.0]HEPTANE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/20/2021
|
Application #:
|
16621943
|
Filing Dt:
|
12/12/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/09/2020
| | | | |
|
Title:
|
5-(PYRIDIN-3-YL)OXAZOLE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/24/2022
|
Application #:
|
16621953
|
Filing Dt:
|
12/12/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/09/2021
| | | | |
|
Title:
|
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/19/2021
|
Application #:
|
16621959
|
Filing Dt:
|
12/12/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/02/2020
| | | | |
|
Title:
|
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2022
|
Application #:
|
16622323
|
Filing Dt:
|
12/13/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2020
| | | | |
|
Title:
|
A NOVEL CRYSTALLINE FORM OF A BACE INHIBITOR, COMPOSITIONS, AND USE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/28/2021
|
Application #:
|
16631191
|
Filing Dt:
|
01/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/09/2020
| | | | |
|
Title:
|
SUBSTITUTED PHENYL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/31/2021
|
Application #:
|
16631192
|
Filing Dt:
|
01/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/09/2020
| | | | |
|
Title:
|
SUBSTITUTED PYRIDINYL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/28/2021
|
Application #:
|
16631673
|
Filing Dt:
|
01/16/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/10/2020
| | | | |
|
Title:
|
Metallo-Beta-Lactamase Inhibitors and Methods of Use Thereof
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/26/2022
|
Application #:
|
16635059
|
Filing Dt:
|
01/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/06/2021
| | | | |
|
Title:
|
Combinations of PD-1 Antagonists and Benzo[b]thiophene STING Agonists for Cancer Treatment
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/29/2022
|
Application #:
|
16635074
|
Filing Dt:
|
01/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/22/2020
| | | | |
|
Title:
|
Benzo[b]thiophene STING Agonists for Cancer Treatment
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2022
|
Application #:
|
16641480
|
Filing Dt:
|
02/24/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/27/2021
| | | | |
|
Title:
|
METHODS FOR PREPARING STABILIZED AMORPHOUS DRUG FORMULATIONS USING ACOUSTIC FUSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/31/2023
|
Application #:
|
16643881
|
Filing Dt:
|
03/03/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/27/2020
| | | | |
|
Title:
|
LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16644107
|
Filing Dt:
|
03/04/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/02/2020
| | | | |
|
Title:
|
COMPOUNDS FOR REDUCING THE VISCOSITY OF BIOLOGICAL FORMULATIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/08/2022
|
Application #:
|
16645048
|
Filing Dt:
|
03/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/22/2020
| | | | |
|
Title:
|
PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/13/2022
|
Application #:
|
16645068
|
Filing Dt:
|
03/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
02/11/2021
| | | | |
|
Title:
|
PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/14/2021
|
Application #:
|
16646616
|
Filing Dt:
|
03/12/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/20/2020
| | | | |
|
Title:
|
HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/06/2021
|
Application #:
|
16649756
|
Filing Dt:
|
03/23/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH A COMBINATION OF PROGRAMMED DEATH RECEPTOR (PD-1) ANTIBODIES AND A CXCR2 ANTAGONIST
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/06/2022
|
Application #:
|
16651456
|
Filing Dt:
|
03/27/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/24/2020
| | | | |
|
Title:
|
CHROMANE MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/14/2020
|
Application #:
|
16663490
|
Filing Dt:
|
10/25/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/20/2020
| | | | |
|
Title:
|
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/08/2021
|
Application #:
|
16670093
|
Filing Dt:
|
10/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/07/2020
| | | | |
|
Title:
|
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS PDE9 INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/02/2021
|
Application #:
|
16674546
|
Filing Dt:
|
11/05/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/05/2020
| | | | |
|
Title:
|
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/26/2022
|
Application #:
|
16695367
|
Filing Dt:
|
11/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/15/2021
| | | | |
|
Title:
|
9-SUBSTITUTED AMINO TRIAZOLO QUINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/16/2023
|
Application #:
|
16697575
|
Filing Dt:
|
11/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
|
Title:
|
CTLA4 BINDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/21/2022
|
Application #:
|
16705592
|
Filing Dt:
|
12/06/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/04/2020
| | | | |
|
Title:
|
METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/05/2022
|
Application #:
|
16710724
|
Filing Dt:
|
12/11/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/18/2020
| | | | |
|
Title:
|
INCLUSION COMPLEXES OF AN HCV NS5B INHIBITOR AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/24/2022
|
Application #:
|
16710875
|
Filing Dt:
|
12/11/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/02/2020
| | | | |
|
Title:
|
METHODS FOR THE TREATMENT AND PROPHYLAXIS OF HIV AND AIDS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/09/2023
|
Application #:
|
16717509
|
Filing Dt:
|
12/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/25/2020
| | | | |
|
Title:
|
COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16724984
|
Filing Dt:
|
12/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
|
Title:
|
ANTI-CD27 ANTIBODIES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/19/2021
|
Application #:
|
16746725
|
Filing Dt:
|
01/17/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/16/2020
| | | | |
|
Title:
|
HUMANIZED ANTIBODY FOR TREATING OR PREVENTING COGNITIVE DISORDERS, PROCESS FOR PRODUCING THE SAME, AND AGENT FOR TREATING OR PREVENTING COGNITIVE DISORDERS USING THE SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2022
|
Application #:
|
16753035
|
Filing Dt:
|
04/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
|
Title:
|
NOVEL SUBSTITUTED CYCLOBUTYLBENZENE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2022
|
Application #:
|
16753043
|
Filing Dt:
|
04/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/30/2020
| | | | |
|
Title:
|
NOVEL SUBSTITUTED PHENYLOXETANE AND PHENYLTETRAHYDROFURAN COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/07/2021
|
Application #:
|
16753050
|
Filing Dt:
|
04/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/17/2020
| | | | |
|
Title:
|
NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/02/2021
|
Application #:
|
16755172
|
Filing Dt:
|
04/10/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/24/2021
| | | | |
|
Title:
|
INDAZOLYL-SPIRO[2.2]PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/16/2021
|
Application #:
|
16755177
|
Filing Dt:
|
04/10/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/24/2021
| | | | |
|
Title:
|
INDAZOLYL-SPIRO[2.3]HEXANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16758717
|
Filing Dt:
|
04/23/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2021
| | | | |
|
Title:
|
NOVEL SUBSTITUTED TETRAHYDROQUINOLIN COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16759167
|
Filing Dt:
|
04/24/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/15/2020
| | | | |
|
Title:
|
ADJUVANTED VACCINES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16760571
|
Filing Dt:
|
04/30/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/30/2021
| | | | |
|
Title:
|
STABLE FORMULATIONS OF CYTOMEGALOVIRUS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2022
|
Application #:
|
16761855
|
Filing Dt:
|
05/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/14/2021
| | | | |
|
Title:
|
NOVEL SUBSTITUTED BIARYL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/24/2021
|
Application #:
|
16762114
|
Filing Dt:
|
05/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
11/12/2020
| | | | |
|
Title:
|
PRMT5 INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/16/2021
|
Application #:
|
16762201
|
Filing Dt:
|
05/07/2020
|
|
Publication #:
|
|
Pub Dt:
|
11/19/2020
| | | | |
|
Title:
|
PRMT5 INHIBITORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/23/2021
|
Application #:
|
16764107
|
Filing Dt:
|
05/14/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/17/2020
| | | | |
|
Title:
|
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/25/2022
|
Application #:
|
16764448
|
Filing Dt:
|
05/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/17/2020
| | | | |
|
Title:
|
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2022
|
Application #:
|
16769603
|
Filing Dt:
|
06/04/2020
|
|
Publication #:
|
|
Pub Dt:
|
02/25/2021
| | | | |
|
Title:
|
SUBSTITUTED IMIDAZO[1,2-c]QUINAZOLINES AS A2A ANTAGONISTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16769837
|
Filing Dt:
|
06/04/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/17/2020
| | | | |
|
Title:
|
FORMULATIONS OF DENGUE VIRUS VACCINE COMPOSITIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/27/2023
|
Application #:
|
16771814
|
Filing Dt:
|
06/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/08/2021
| | | | |
|
Title:
|
CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/21/2023
|
Application #:
|
16771818
|
Filing Dt:
|
06/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/01/2021
| | | | |
|
Title:
|
CONJUGATE BASED SYSTEMS FOR CONTROLLED INSULIN DELIVERY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/27/2022
|
Application #:
|
16772044
|
Filing Dt:
|
06/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
11/19/2020
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITIONS OF TEDIZOLID PHOSPHATE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/24/2021
|
Application #:
|
16787201
|
Filing Dt:
|
02/11/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/13/2020
| | | | |
|
Title:
|
5-ALKYL PYRROLIDINE OREXIN RECEPTOR AGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/14/2020
|
Application #:
|
16789123
|
Filing Dt:
|
02/12/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/11/2020
| | | | |
|
Title:
|
(S)-N-(3-6-ISOPROPOXYPYRIDIN-3-3YL)-1H-INDAZOL-5-YL)-1-(2-(4-4(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H-YL)-2-OXOETHYL)-3(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS
|
|
